Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 5/20 | 0.46 |
| ▸ | LMNA | P02545 | 5/20 | 0.46 |
| ▸ | POLB | P06746 | 3/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | SREBF2 | Q12772 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13680940 | 0.89 | TP53 (0.45) | TP53LMNAPOLBRXFP1MAPT | |
| SCHEMBL13680933 | 0.85 | SREBF2 (0.51) | TP53LMNAPOLBRXFP1MAPT | |
| SCHEMBL13680934 | 0.83 | TP53 (0.51) | TP53LMNAPOLBRXFP1MAPT | |
| SCHEMBL13680936 | 0.83 | TP53 (0.46) | TP53LMNAPOLBRXFP1MAPT | |
| SCHEMBL13680938 | 0.82 | MEN1 (0.49) | TP53LMNAPOLBRXFP1MAPT | |
| SCHEMBL13681034 | 0.80 | MEN1 (0.46) | TP53LMNAPOLBRXFP1MAPT | |
| SCHEMBL13680574 | 0.80 | RAB9A (0.49) | TP53LMNAPOLBMAPTMAOA | |
| SCHEMBL13680932 | 0.76 | KMT2A (0.47) | TP53LMNAPOLBRXFP1MAPT | |
| SCHEMBL13680948 | 0.75 | SREBF1 (0.51) | TP53LMNAMAPTMEN1KMT2A | |
| SCHEMBL13680946 | 0.75 | AVPR1B (0.47) | TP53LMNAPOLBRXFP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7582658-B2 | Bicyclic compound | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-09-01 | — | — | US | disclosed |
| US-7582658-B2 | Bicyclic compound | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-09-01 | — | — | US | disclosed |